Aberrant methylation of six genes (SFN, P16, hMLH1, HOXD13, PCDHGB7, and RASSF1a) in serum cfDNA of breast cancer patients in comparison to the healthy subjects and those with benign breast disease. This evidence concerns the gene SFN and breast fibrocystic disease.